| LLY |
Eli Lilly and Company |
704.72B |
18.35% |
|
|
|
|
|
742.35 |
2.29% |
36.06% |
35.13% |
|---|
| BMY |
Bristol-Myers Squibb Company |
115.69B |
7.03% |
|
|
|
|
|
57.04 |
1.33% |
26.07% |
39.82% |
|---|
| NVS |
Novartis AG |
195.12B |
6.59% |
|
|
|
|
|
99.73 |
2.26% |
24.34% |
69.87% |
|---|
| AMGN |
Amgen Inc. |
147.72B |
6.15% |
|
|
|
|
|
274.81 |
0.99% |
27.86% |
24.94% |
|---|
| AZN |
AstraZeneca PLC |
210.75B |
5.78% |
|
|
|
|
|
67.96 |
2.04% |
29.19% |
69.45% |
|---|
| USBGFS7 |
US BANK MMDA - USBGFS 7 06/01/2031 |
|
5.21% |
|
|
|
|
|
|
|
|
|
|---|
| JNJ |
Johnson & Johnson |
356.69B |
5.17% |
|
|
|
|
|
148.15 |
0.76% |
19.03% |
41.70% |
|---|
| PFE |
Pfizer Inc. |
150.97B |
4.83% |
|
|
|
|
|
26.64 |
1.29% |
28.29% |
56.47% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
34.18B |
4.80% |
|
|
|
|
|
264.99 |
7.60% |
33.02% |
21.33% |
|---|
| ALKS |
Alkermes plc |
4.87B |
4.68% |
|
|
|
|
|
30.10 |
2.14% |
46.26% |
68.15% |
|---|
| MRK |
Merck & Co., Inc. |
243.45B |
4.67% |
|
|
|
|
|
96.24 |
-1.72% |
29.23% |
82.06% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
74.33B |
3.57% |
|
|
|
|
|
687.80 |
0.91% |
35.86% |
61.72% |
|---|
| BIIB |
Biogen Inc. |
20.54B |
3.31% |
|
|
|
|
|
140.98 |
0.31% |
37.19% |
62.53% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
5.16B |
3.08% |
|
|
|
|
|
32.68 |
3.98% |
47.94% |
47.62% |
|---|
| CRSP |
CRISPR Therapeutics AG |
3.54B |
2.88% |
|
|
|
|
|
41.51 |
2.42% |
58.04% |
23.81% |
|---|
| GSK |
GSK plc |
68.92B |
2.68% |
|
|
|
|
|
33.78 |
1.05% |
28.12% |
78.18% |
|---|
| BEAM |
Beam Therapeutics Inc. |
2.03B |
1.71% |
|
|
|
|
|
24.53 |
4.65% |
77.41% |
64.63% |
|---|
| BCYC |
Bicycle Therapeutics plc |
935.86M |
1.44% |
|
|
|
|
|
13.56 |
1.65% |
282.95% |
9.17% |
|---|
| REPL |
Replimune Group, Inc. |
892.78M |
1.25% |
|
|
|
|
|
11.85 |
16.86% |
100.82% |
7.48% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
1.01B |
1.16% |
|
|
|
|
|
9.94 |
4.63% |
78.76% |
48.90% |
|---|
| HLN |
Haleon plc |
41.83B |
0.95% |
|
|
|
|
|
9.24 |
0.00% |
67.63% |
56.38% |
|---|
| VNDA |
Vanda Pharmaceuticals Inc. |
262.97M |
0.87% |
|
|
|
|
|
4.51 |
3.44% |
65.63% |
22.57% |
|---|
| LTRN |
Lantern Pharma Inc. |
43.89M |
0.67% |
|
|
|
|
|
4.07 |
10.30% |
469.47% |
26.63% |
|---|
| SDZNY |
Sandoz Group AG |
|
0.56% |
|
|
|
|
|
|
|
|
|
|---|
| GEHC |
GE HealthCare Technologies Inc. |
39.90B |
0.53% |
|
|
|
|
|
87.34 |
3.07% |
28.11% |
58.63% |
|---|
| GALT |
Galectin Therapeutics Inc. |
76.64M |
0.42% |
|
|
|
|
|
1.2300 |
-0.81% |
147.16% |
15.16% |
|---|
| TSVT |
2seventy bio, Inc. |
126.39M |
0.35% |
|
|
|
|
|
2.4500 |
-6.13% |
199.21% |
34.39% |
|---|
| VTRS |
Viatris Inc. |
13.52B |
0.31% |
|
|
|
|
|
11.33 |
0.27% |
27.64% |
37.90% |
|---|
| ALLO |
Allogene Therapeutics, Inc. |
385.80M |
0.29% |
|
|
|
|
|
1.8400 |
1.10% |
408.42% |
43.75% |
|---|
| EDIT |
Editas Medicine, Inc. |
99.88M |
0.27% |
|
|
|
|
|
1.2100 |
-0.82% |
83.32% |
32.07% |
|---|
| PACB |
Pacific Biosciences of California, Inc. |
465.57M |
0.15% |
|
|
|
|
|
1.7000 |
3.66% |
116.19% |
43.41% |
|---|
| Cash&Other |
Cash & Other |
|
0.14% |
|
|
|
|
|
|
|
|
|
|---|
| BLUE |
bluebird bio, Inc. |
79.14M |
0.10% |
|
|
|
|
|
8.14 |
-2.52% |
126.16% |
25.42% |
|---|
| MURA |
Mural Oncology plc |
70.63M |
0.05% |
|
|
|
|
|
4.14 |
3.50% |
370.05% |
39.09% |
|---|
| SLRX |
Salarius Pharmaceuticals, Inc. |
3.57M |
0.04% |
|
|
|
|
|
2.4800 |
-7.81% |
N/A |
N/A |
|---|
| 2368714D |
Pathos AI Inc |
|
N/A |
|
|
|
|
|
|
|
|
|
|---|